# OnCo record lisata (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/lisata/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "lisata" ;
  schema:name "Lisata Therapeutics"@en ;
  schema:alternateName "Lisata Therapeutics, Inc."@en, "Caladrius Biosciences"@en, "Cend Therapeutics"@en ;
  schema:description "Lisata is a New Jersey biotech developing certepetide, a peptide that opens up the dense stroma of pancreatic tumours so chemotherapy can reach the cancer cells; it is tested with gemcitabine and nab-paclitaxel."@en ;
  schema:url <https://onco.cc/companies/lisata/>, <https://www.lisata.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.lisata.com>, <https://clinicaltrials.gov/search?lead=Lisata%20Therapeutics%2C%20Inc.> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/> ;
  onco:terms <https://onco.cc/terms/pivotal-trial/>, <https://onco.cc/terms/clinical-trial/> .